Approvals/CIMA-AEMPS/AMBRISENTAN BLUEFISH 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

AMBRISENTAN BLUEFISH 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Bluefish Pharmaceuticals Ab (Publ)🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 935b67d64f9d9206
Drug Cima Aemps Name: AMBRISENTAN BLUEFISH 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 86714
Holder Company Name: Bluefish Pharmaceuticals Ab (Publ)
Marketing Company Name: Bluefish Pharma S.L.U.
Authorization Date: 2022-03-31
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Bluefish Pharmaceuticals Ab (Publ)

AMBRISENTAN

5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 31, 2022

Approval ID

935b67d64f9d9206

Type

Standard